Impact of high-dose chemotherapy followed by auto-SCT for positive interim [18F] FDG-PET diffuse large B-cell lymphoma patients.

Roland, V; Bodet-Milin, C; Moreau, A; Gastinne, T; Mahé, B; Dubruille, V; Maisonneuve, H; Juge-Morineau, N; Moreau, P; Jardel, H; Planche, L; Mohty, M; Moreau, P; Harousseau, J-L; Kraeber-Bodéré, F; Le Gouill, S

Roland, V; Bodet-Milin, C; Moreau, A; Gastinne, T; Mahé, B; Dubruille, V; Maisonneuve, H; Juge-Morineau, N; Moreau, P; Jardel, H; Planche, L; Mohty, M; Moreau, P; Harousseau, J-L; Kraeber-Bodéré, F; Le Gouill, S.

Affiliation

Roland V; Centre Hospitalier Universitaire de Nantes, Service d'Hématologie Clinique, Nantes, France.

Bone Marrow Transplant ; 46(3): 393-9, 2011 Mar.

Article in En | MEDLINE | ID: mdl-20577223

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Fluorodeoxyglucose F18; Lymphoma, Large B-Cell, Diffuse/diagnostic imaging; Lymphoma, Large B-Cell, Diffuse/therapy; Stem Cell Transplantation; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols/administration & dosage; Combined Modality Therapy; Dose-Response Relationship, Drug; Female; Humans; Lymphoma, Large B-Cell, Diffuse/drug therapy; Lymphoma, Large B-Cell, Diffuse/surgery; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Treatment Outcome; Young Adult

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Lymphoma, Large B-Cell, Diffuse / Fluorodeoxyglucose F18 / Stem Cell Transplantation Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Bone Marrow Transplant Year: 2011 Document type: Article

Fulltext

XML

PubMed Links

Search on Google